Movement disorders are a group of nervous system conditions that cause you to have abnormal voluntary or involuntary movements, or slow, reduced movements.
Deep Brain Stimulation (DBS) uses a surgically implanted, battery-operated medical device to deliver electrical stimulation to specific areas in the brain that control movement. This blocks the abnormal nerve signals that cause symptoms.
Researchers at the Bionics Institute have discovered a unique brain signal (a biomarker) in patients receiving DBS implants for the treatment of Parkinson’s disease. Using this signal, we aim to improve the outcomes of deep brain stimulation treatment.
Click here to download our factsheet on Deep Brain Stimulation.
Click on the projects listed below for more information.
The aim is to validate ERNA as a biomarker for adaptive DBS in the treatment of Parkinson's disease.
Developing a system that measures ERNA.
Developing a closed-loop deep brain stimulation device.
The Bionics Institute Rigidity Device (BiRD) is designed to monitor the four main symptoms of Parkinson's disease.